130.99  -1.01 (-0.77%)		09-11 16:00
Open: 133.505 High: 134.09 Volume: 570,062		Pre. Close: 132 Low: 128.98 Market Cap: 5,799(M)

Short term
Mid term
Targets	6-month :	161.6	1-year :	168.37
Resists	First :	138.36	Second :	144.16
Pivot price	138.06
Supports	First :	128.97	Second :	107.31
MAs	MA(5) :	134.81	MA(20) :	137.19
	MA(100) :	132.2	MA(250) :	122.49
MACD	MACD :	-0.2	Signal :	0.9
%K %D	K(14,3) :	15.9	D(3) :	28.6
RSI	RSI(14): 38.5
52-week	High :	144.64	Low :	99.38

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
[ TFX ] has closed below the lower bollinger band by 8.8%. If price is in a downtrend band; this downward trend might continue. However a short term pullback inside the band is likely. Bollinger Bands are 12.7% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

If tomorrow:	Open lower	Open higher
High:	134.97 - 136.26	136.26 - 137.04
Low:	126.25 - 127.93	127.93 - 128.95
Close:	129.06 - 131.8	131.8 - 133.46

Teleflex Incorporated is a global medical technology company dedicated to designing, developing, manufacturing, and distributing single-use medical devices. These products are crucial for diagnostic and therapeutic procedures, particularly within critical care and surgical environments worldwide. Its comprehensive product portfolio includes: Vascular Access Solutions: Featuring the "Arrow" brand, these include catheters, advanced catheter navigation and tip positioning systems, and intraosseous access systems. They are essential for administering intravenous therapies, monitoring blood pressure, and drawing blood samples, all achievable through a single access point. Interventional Cardiology & Radiology Products: This segment covers various coronary catheters, therapies for structural heart conditions, and devices for peripheral intervention and cardiac assist. Key users include interventional cardiologists, radiologists, and vascular surgeons. Specific offerings comprise Arrow, Guideline, and Trapliner catheters, the Manta Vascular Closure Device, and Arrow Oncontrol systems. Anesthesia and Surgical Products: The company provides anesthesia and pain management products, serving hospitals, emergency medical services, and military health organizations. Its surgical division offers metal and polymer ligation clips, fascial closure systems for laparoscopic procedures, percutaneous surgical systems, and a range of other surgical instruments. Interventional Urology & General Urology: Teleflex's interventional urology offerings prominently feature the UroLift System, an innovative treatment for lower urinary tract symptoms associated with benign prostatic hyperplasia (BPH). Additionally, it supplies general urology products like catheters, urine collection devices, catheterization accessories, and tools for operative endourology, alongside providing bladder management services. Respiratory Care Products: This category includes oxygen and aerosol therapy devices, spirometry equipment, and ventilation management systems, applicable across diverse healthcare settings. Teleflex serves a broad customer base, encompassing hospitals, healthcare providers, medical device manufacturers, and the home care market. Established in 1943, the company maintains its headquarters in Wayne, Pennsylvania.

Thu, 10 Sep 2026
Director Sean Salmon receives Teleflex (NYSE: TFX) stock and options - stocktitan.net

Thu, 10 Sep 2026
New Teleflex (NYSE: TFX) director Sean Salmon reports no stock stake - stocktitan.net

Wed, 09 Sep 2026
Surgical Equipment & Consumables - Specialty Stocks Q2 Earnings Review: Teleflex (NYSE:TFX) Shines - finance.yahoo.com

Tue, 08 Sep 2026
Teleflex Appoints Veteran Medical Technology Executive Sean M. Salmon to Teleflex Board of Directors - Teleflex

Mon, 07 Sep 2026
Teleflex Incorporated (TFX): Stock Analysis Highlights A Promising 10.98% Upside Potential - DirectorsTalk Interviews

Fri, 04 Sep 2026
Teleflex Stock Price Forecast. Should You Buy TFX? - StockInvest.us

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Neutral
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Outperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Underperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NYSE
Sector: Healthcare
Industry: Medical - Instruments & Supplies
Shares Out	42 (M)
Shares Float	42 (M)
Held by Insiders	0.6 (%)
Held by Institutions	114.6 (%)
Shares Short	4,840 (K)
Shares Short P.Month	2,780 (K)

EPS	-0.53
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	68.55
Profit Margin	-45.8 %
Operating Margin	10 %
Return on Assets (ttm)	1.7 %
Return on Equity (ttm)	-0.7 %
Qtrly Rev. Growth	28.8 %
Gross Profit (p.s.)	29.26
Sales Per Share	53.1
EBITDA (p.s.)	9.53
Qtrly Earnings Growth	-17.3 %
Operating Cash Flow	403 (M)
Levered Free Cash Flow	180 (M)

PE Ratio	-247.16
PEG Ratio	0.1
Price to Book value	1.91
Price to Sales	2.46
Price to Cash Flow	13.76

Dividend	0.34
Forward Dividend	0
Dividend Yield	0.2%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.